A Novel UPLC Method Development and Validation for the Estimation of Paracetamol and Chlormezanone in Dosage Form

Authors

  • Teja Sri Adla
  • Sandhya Mamindla

DOI:

https://doi.org/10.37591/(rrjops).v11i1.733

Abstract

A simple, rapid, specific, accurate and precise Ultra High-Performance Liquid Chromatographic (HPLC) method was developed for the estimation of paracetamol and chlormezanone in dosage forms. Water Acquity C18 (100×2.1 mm ID) 1.8 µm was the column used. Methanol: Water: TEA (Tri ethyl amine) in the ratio of 50:50:0.5% (v/v/v) was the optimized mobile phase and pH was adjusted to 7.5 by using Ortho Phosphoric Acid. The flow rate was 0.5 ml/min and effluents were monitored at 266 nm. The method was validated for linearity, accuracy, precision, specificity and sensitivity. The retention time of paracetamol and chlormezanone was found to be 2.35 and 4.46 min, respectively. Limit of Detection (LOD) for paracetamol and chlormezanone were found to be 14.34 and 4.13 µg/ml, respectively and Limit of Quantitation (LOQ) for paracetamol and chlormezanone were found to be 43.48 and 12.53 µg/ml, respectively.

 

Keywords: Chlormezanone, LOD, LOQ, UPLC, Paracetamol

 

Cite this Article

Teja Sri Adla, Sandhya Mamindla. A Novel UPLC Method Development and Validation for the Estimation of Paracetamol and Chlormezanone in Dosage Form. Research and Reviews: A Journal of Pharmaceutical Science. 2020; 11(1): 1–8p.

Downloads

Published

2020-05-21

Issue

Vol. 11 No. 1 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.